These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4639301)

  • 1. Structure-activity correlations between hydroxamic acids and their inhibitory powers on urease activity. I. A quantitative approach to the effect of hydrophobic character of acyl residue.
    Kumaki K; Tomioka S; Kobashi K; Hase J
    Chem Pharm Bull (Tokyo); 1972 Aug; 20(8):1599-606. PubMed ID: 4639301
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative structure-activity relationships between hydroxamic acids and their urease inhibitory potency.
    Munakata K; Kobashi K; Hase J
    J Pharmacobiodyn; 1980 Sep; 3(9):457-62. PubMed ID: 7463305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of urease activity by hydroxamic acid derivatives of amino acids.
    Kobashi K; Takebe S; Terashima N; Hase J
    J Biochem; 1975 Apr; 77(4):837-43. PubMed ID: 238968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urease inhibition by hydroxamic acids.
    Akers HA
    Experientia; 1981 Mar; 37(3):229-30. PubMed ID: 7238770
    [No Abstract]   [Full Text] [Related]  

  • 5. Study on hydroxamic acids and their urease inhibitory potency by quantum chemistry calculation.
    Kanoda M; Shinoda H; Kobashi K; Hase J; Nagahara S
    J Pharmacobiodyn; 1983 Feb; 6(2):61-70. PubMed ID: 6864441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of urease activity by dipeptidyl hydroxamic acids.
    Odake S; Nakahashi K; Morikawa T; Takebe S; Kobashi K
    Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2764-8. PubMed ID: 1464106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CoMFA and CoMSIA 3D-QSAR analysis on hydroxamic acid derivatives as urease inhibitors.
    Ul-Haq Z; Wadood A; Uddin R
    J Enzyme Inhib Med Chem; 2009 Feb; 24(1):272-8. PubMed ID: 18608766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of urease activity but not growth of Helicobacter pylori by acetohydroxamic acid.
    Goldie J; Veldhuyzen van Zanten SJ; Jalali S; Richardson H; Hunt RH
    J Clin Pathol; 1991 Aug; 44(8):695-7. PubMed ID: 1890207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of urease by hydroxamic acids.
    Gale GR; Atkins LM
    Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):289-98. PubMed ID: 5348403
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.
    Xiao ZP; Peng ZY; Dong JJ; Deng RC; Wang XD; Ouyang H; Yang P; He J; Wang YF; Zhu M; Peng XC; Peng WX; Zhu HL
    Eur J Med Chem; 2013 Oct; 68():212-21. PubMed ID: 23974021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Proteus vulgaris urease by hydroxamic acids.
    Hase J; Kobashi K
    J Biochem; 1967 Sep; 62(3):293-9. PubMed ID: 5586497
    [No Abstract]   [Full Text] [Related]  

  • 12. Urease activity of Helicobacter pylori.
    Kobashi K
    J Clin Pathol; 1992 Apr; 45(4):367-8. PubMed ID: 1577984
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of Jack Bean urease (EC 3.5.1.5) by acetohydroxamic acid and by phosphoramidate. An equivalent weight for urease.
    Dixon NE; Gazzola C; Watters JJ; Blakely RL; Zerner B
    J Am Chem Soc; 1975 Jul; 97(14):4130-1. PubMed ID: 1159215
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy for urolithiasis by hydroxamic acids. II. Urease inhibitory potency and urinary excretion rate of hippurohydroxamic acid derivatives.
    Kobashi K; Munakata K; Takebe S; Hase J
    J Pharmacobiodyn; 1980 Sep; 3(9):444-50. PubMed ID: 7007613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of caprylohydroxamic acid on ruminal urease.
    Shimbayashi K; Obara Y; Yonemura T; Deguchi N; Nakanishi M
    Nihon Juigaku Zasshi; 1973 Aug; 35(4):327-34. PubMed ID: 4797147
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis and biological evaluation of O-methyl and O-ethyl NSAID hydroxamic acids.
    Rajić Z; Perković I; Butula I; Zorc B; Hadjipavlou-Litina D; Pontiki E; Pepeljnjak S; Kosalec I
    J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1179-87. PubMed ID: 19772490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acyl residues of hydroxamic acids on urease inhibition.
    Kobashi K; Kumaki K; Hase JI
    Biochim Biophys Acta; 1971 Feb; 227(2):429-41. PubMed ID: 5550827
    [No Abstract]   [Full Text] [Related]  

  • 18. Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection.
    Liu Q; Shi WK; Ren SZ; Ni WW; Li WY; Chen HM; Liu P; Yuan J; He XS; Liu JJ; Cao P; Yang PZ; Xiao ZP; Zhu HL
    Eur J Med Chem; 2018 Aug; 156():126-136. PubMed ID: 30006158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of beta-glucosyl-phenolic hydroxamic acids against urease in the presence of microfloral beta-glucosidase.
    Park JB; Imamura L; Kobashi K; Itoh H; Miyazaki T; Horisaki T
    Biol Pharm Bull; 1995 Feb; 18(2):208-13. PubMed ID: 7742785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro inhibition of rumen urease with acetohydroxamic acid.
    Brent BE; Adepoju A; Portela F
    J Anim Sci; 1971 Apr; 32(4):794-8. PubMed ID: 5571567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.